EDGAR Filing Documents for 0001558370-24-007041

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001558370-24-007041

Filing Date

2024-05-07

Accepted

2024-05-07 16:05:52

Documents

Period of Report

2024-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	rigl-20240331x10q.htm iXBRL	10-Q	1997535
2	EX-10.1	rigl-20240331xex10d1.htm	EX-10.1	594494
3	EX-10.2	rigl-20240331xex10d2.htm	EX-10.2	22171
4	EX-10.3	rigl-20240331xex10d3.htm	EX-10.3	151235
5	EX-10.4	rigl-20240331xex10d4.htm	EX-10.4	144033
6	EX-31.1	rigl-20240331xex31d1.htm	EX-31.1	15893
7	EX-31.2	rigl-20240331xex31d2.htm	EX-31.2	16779
8	EX-32.1	rigl-20240331xex32d1.htm	EX-32.1	9071
9	GRAPHIC	rigl-20240331x10q004.jpg	GRAPHIC	75376
	Complete submission text file	0001558370-24-007041.txt		9257632

Data Files

Seq	Description	Document	Type	Size
10	EX-101.SCH	rigl-20240331.xsd	EX-101.SCH	56451
11	EX-101.CAL	rigl-20240331_cal.xml	EX-101.CAL	61198
12	EX-101.DEF	rigl-20240331_def.xml	EX-101.DEF	227110
13	EX-101.LAB	rigl-20240331_lab.xml	EX-101.LAB	479311
14	EX-101.PRE	rigl-20240331_pre.xml	EX-101.PRE	360249
84	EXTRACTED XBRL INSTANCE DOCUMENT	rigl-20240331x10q_htm.xml	XML	1308759

Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080

Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100

RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)